Under the terms of the agreement, Panther has licensed from the University of Rochester, the rights to develop and commercialize a first in class new chemical entity with demonstrated powerful anti-leukemia activity. The licensed compound, called TDZD-8, is a small molecule engineered to kill leukemic stem cells.
http://ift.tt/1cCm1iU
http://ift.tt/1cCm1iU
No comments:
Post a Comment